跳至主要内容
临床试验/JPRN-UMIN000006355
JPRN-UMIN000006355已完成2 期

Pemetrexed Monotherapy for Performance Status 2 Patients in Treatment of Relapsed Non-squamous and Non-small Cell Lung Cancer - Pemetrexed monotherapy for PS2 patients with Non-sq NSCLC

Hanshin Cancer Study Group0 个研究点目标入组 35 人开始时间: 2011年9月15日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Interstitial pneumonia or pulmonary fibrosis detectable on CT scan 2)History of drug induced interstitial pneumonia 3)History of severe drug allergy 4)History of active infection or other serious disease condition (GI bleeding,etc.) 5)History of poorly controlled pleural effusion,pericardial effusion and ascites 6)History of severe heart disease(uncontrollable arrythmia, uncontrollable angina pectoris, herat failure, etc.) 7)Uncontrollable diabetes mellitus 8)History of symptomatic brain metastases 9)Hystory of active double cancer 10)History of active psychological disease 11)Patients whose participation in the trial is judged to be inappropriate by the attending doctor

研究者

发起方
Hanshin Cancer Study Group

相似试验